SLC1A5, unrelated to prognosis, was associated with CD8+ T-cell exclusion in the tumor microenvironment of squamous cell carcinoma
SLC1A5, short for solute carrier family 1 member 5, is a neutral amino acid transporter whose expression has been reported to be upregulated in various cancers, including esophageal squamous cell carcinoma (ESCC). Despite this, little has been described regarding the immunological involvement of SLC...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-03-01
|
| Series: | Heliyon |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844023017784 |
| _version_ | 1797851776650575872 |
|---|---|
| author | Shutao Zheng Tao Liu Lu Li Qing Liu Conggai Huang Yan Liang Yiyi Tan Li Zhang Xiaomei Lu |
| author_facet | Shutao Zheng Tao Liu Lu Li Qing Liu Conggai Huang Yan Liang Yiyi Tan Li Zhang Xiaomei Lu |
| author_sort | Shutao Zheng |
| collection | DOAJ |
| description | SLC1A5, short for solute carrier family 1 member 5, is a neutral amino acid transporter whose expression has been reported to be upregulated in various cancers, including esophageal squamous cell carcinoma (ESCC). Despite this, little has been described regarding the immunological involvement of SLC1A5 expression in the tumor microenvironment of ESCC. Given this, we adopted in silico analyses together with a wet lab strategy to investigate the prognostic and clinicopathological meaning of SLC1A5 expression in ESCC. In silico analyses of SLC1A5 expression data available from The Cancer Genome Atlas (TCGA) database revealed that SLC1A5 expression was unrelated to the prognosis of ESCC, which holds true when extended to other types of squamous cell carcinoma (SCC), including head and neck squamous cell carcinoma (HNSC) and lung squamous cell carcinoma (LUSC). Further analyses revealed that SLC1A5 expression correlated markedly with the infiltration density of effector CD8+ T cells in ESCC, and the same was true for HNSC and LUSC when extrapolated. As experimental confirmation, multiplexed immunofluorescent staining was undertaken to verify the correlation between SLC1A5 expression and infiltration of CD8+ T cells in a tissue microarray prepared from ESCC and matched normal control tissues. Our data confirmed that SLC1A5 expression was not associated with prognosis but was associated with the exclusion of CD8+ T cells. Taken together, all the data we curated strongly support the notion that SLC1A5 expression is associated with CD8+ T-cell exclusion in the tumor microenvironment of SCC. |
| first_indexed | 2024-04-09T19:22:14Z |
| format | Article |
| id | doaj.art-524c3f1154464cfcb26b917d4635963f |
| institution | Directory Open Access Journal |
| issn | 2405-8440 |
| language | English |
| last_indexed | 2024-04-09T19:22:14Z |
| publishDate | 2023-03-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Heliyon |
| spelling | doaj.art-524c3f1154464cfcb26b917d4635963f2023-04-05T08:27:02ZengElsevierHeliyon2405-84402023-03-0193e14571SLC1A5, unrelated to prognosis, was associated with CD8+ T-cell exclusion in the tumor microenvironment of squamous cell carcinomaShutao Zheng0Tao Liu1Lu Li2Qing Liu3Conggai Huang4Yan Liang5Yiyi Tan6Li Zhang7Xiaomei Lu8State Key Laboratory of Pathogenesis, Prevention, Treatment of Central Asian High Incidence Diseases, Xinjiang Uygur Autonomous Region, Urumqi, PR China; Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, PR ChinaDepartment of Clinical Laboratory, First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, PR ChinaDepartment of Clinical Laboratory, First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, PR ChinaState Key Laboratory of Pathogenesis, Prevention, Treatment of Central Asian High Incidence Diseases, Xinjiang Uygur Autonomous Region, Urumqi, PR China; Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, PR ChinaState Key Laboratory of Pathogenesis, Prevention, Treatment of Central Asian High Incidence Diseases, Xinjiang Uygur Autonomous Region, Urumqi, PR China; Department of Pathology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, ChinaDepartment of Pathology, Basic Medicine College, Xinjiang Medical University, Urumqi, 830017, ChinaClinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, PR ChinaState Key Laboratory of Pathogenesis, Prevention, Treatment of Central Asian High Incidence Diseases, Xinjiang Uygur Autonomous Region, Urumqi, PR China; VIP Medicine, First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, PR ChinaState Key Laboratory of Pathogenesis, Prevention, Treatment of Central Asian High Incidence Diseases, Xinjiang Uygur Autonomous Region, Urumqi, PR China; Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, PR China; Corresponding author. State Key Laboratory of Pathogenesis, Prevention, Treatment of Central Asian High Incidence Diseases, Xinjiang Uygur Autonomous Region, Urumqi, PR China.SLC1A5, short for solute carrier family 1 member 5, is a neutral amino acid transporter whose expression has been reported to be upregulated in various cancers, including esophageal squamous cell carcinoma (ESCC). Despite this, little has been described regarding the immunological involvement of SLC1A5 expression in the tumor microenvironment of ESCC. Given this, we adopted in silico analyses together with a wet lab strategy to investigate the prognostic and clinicopathological meaning of SLC1A5 expression in ESCC. In silico analyses of SLC1A5 expression data available from The Cancer Genome Atlas (TCGA) database revealed that SLC1A5 expression was unrelated to the prognosis of ESCC, which holds true when extended to other types of squamous cell carcinoma (SCC), including head and neck squamous cell carcinoma (HNSC) and lung squamous cell carcinoma (LUSC). Further analyses revealed that SLC1A5 expression correlated markedly with the infiltration density of effector CD8+ T cells in ESCC, and the same was true for HNSC and LUSC when extrapolated. As experimental confirmation, multiplexed immunofluorescent staining was undertaken to verify the correlation between SLC1A5 expression and infiltration of CD8+ T cells in a tissue microarray prepared from ESCC and matched normal control tissues. Our data confirmed that SLC1A5 expression was not associated with prognosis but was associated with the exclusion of CD8+ T cells. Taken together, all the data we curated strongly support the notion that SLC1A5 expression is associated with CD8+ T-cell exclusion in the tumor microenvironment of SCC.http://www.sciencedirect.com/science/article/pii/S2405844023017784SLC1A5Squamous cell carcinoma (SCC)CD8+ TPrognosisExclusion |
| spellingShingle | Shutao Zheng Tao Liu Lu Li Qing Liu Conggai Huang Yan Liang Yiyi Tan Li Zhang Xiaomei Lu SLC1A5, unrelated to prognosis, was associated with CD8+ T-cell exclusion in the tumor microenvironment of squamous cell carcinoma Heliyon SLC1A5 Squamous cell carcinoma (SCC) CD8+ T Prognosis Exclusion |
| title | SLC1A5, unrelated to prognosis, was associated with CD8+ T-cell exclusion in the tumor microenvironment of squamous cell carcinoma |
| title_full | SLC1A5, unrelated to prognosis, was associated with CD8+ T-cell exclusion in the tumor microenvironment of squamous cell carcinoma |
| title_fullStr | SLC1A5, unrelated to prognosis, was associated with CD8+ T-cell exclusion in the tumor microenvironment of squamous cell carcinoma |
| title_full_unstemmed | SLC1A5, unrelated to prognosis, was associated with CD8+ T-cell exclusion in the tumor microenvironment of squamous cell carcinoma |
| title_short | SLC1A5, unrelated to prognosis, was associated with CD8+ T-cell exclusion in the tumor microenvironment of squamous cell carcinoma |
| title_sort | slc1a5 unrelated to prognosis was associated with cd8 t cell exclusion in the tumor microenvironment of squamous cell carcinoma |
| topic | SLC1A5 Squamous cell carcinoma (SCC) CD8+ T Prognosis Exclusion |
| url | http://www.sciencedirect.com/science/article/pii/S2405844023017784 |
| work_keys_str_mv | AT shutaozheng slc1a5unrelatedtoprognosiswasassociatedwithcd8tcellexclusioninthetumormicroenvironmentofsquamouscellcarcinoma AT taoliu slc1a5unrelatedtoprognosiswasassociatedwithcd8tcellexclusioninthetumormicroenvironmentofsquamouscellcarcinoma AT luli slc1a5unrelatedtoprognosiswasassociatedwithcd8tcellexclusioninthetumormicroenvironmentofsquamouscellcarcinoma AT qingliu slc1a5unrelatedtoprognosiswasassociatedwithcd8tcellexclusioninthetumormicroenvironmentofsquamouscellcarcinoma AT conggaihuang slc1a5unrelatedtoprognosiswasassociatedwithcd8tcellexclusioninthetumormicroenvironmentofsquamouscellcarcinoma AT yanliang slc1a5unrelatedtoprognosiswasassociatedwithcd8tcellexclusioninthetumormicroenvironmentofsquamouscellcarcinoma AT yiyitan slc1a5unrelatedtoprognosiswasassociatedwithcd8tcellexclusioninthetumormicroenvironmentofsquamouscellcarcinoma AT lizhang slc1a5unrelatedtoprognosiswasassociatedwithcd8tcellexclusioninthetumormicroenvironmentofsquamouscellcarcinoma AT xiaomeilu slc1a5unrelatedtoprognosiswasassociatedwithcd8tcellexclusioninthetumormicroenvironmentofsquamouscellcarcinoma |